Morgan Stanley’s Mobix Labs MOBX Stock Holding History

Morgan Stanley’s Portfolio MOBX Stock Details MOBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,723	Closed	-$22K	–	8375
2025 Q3	$22K	Sell	2,723 -760	-22%	-$6.98K	﹤0.01%	6662
2025 Q2	$26.7K	Sell	3,483 -3,500	-50%	-$26.1K	﹤0.01%	6558
2025 Q1	$62.3K	Sell	6,983 -18	-0.3%	-$211	﹤0.01%	6195
2024 Q4	$119K	Buy	+7,001	New	+$71.3K	﹤0.01%	5989

Other funds holding MOBX

Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

VCWA

Vanguard Capital Wealth Advisors Denver, Colorado $148M AUM 91.21% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Krilogy Financial St. Louis, Missouri $3.38B AUM 30.57% 1-Year Est. Return

Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley's MOBX Position: Q4 2025 in Review

Morgan Stanley sold out of Mobix Labs (MOBX) in Q4 2025, closing a stake of 2,723 shares — an estimated $22K sold.

Morgan Stanley first reported a position in MOBX in Q4 2024 and held it in 4 quarters. The position peaked at $119K in Q4 2024. 24 funds tracked by Wall St. Rank hold MOBX as of Q4 2025.

Morgan Stanley reported no remaining Mobix Labs position as of Q4 2025 after selling out during the quarter.
Morgan Stanley sold 2,723 Mobix Labs shares in Q4 2025, an estimated $22K.
Morgan Stanley first reported a position in Mobix Labs in Q4 2024 and held it in 4 quarters.
Morgan Stanley's Mobix Labs position peaked at $119K in Q4 2024.
24 funds tracked by Wall St. Rank held Mobix Labs as of Q4 2025.

Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.